English press releases

IFF to Release Third Quarter 2023 Results November 6

NEW YORK–(BUSINESS WIRE)– IFF (NYSE:IFF) today announced that it will release its third quarter 2023 earnings results following the market close on Monday, Nov. 6,...

XPENG Hosts its 2023 TECH DAY: Advancing Leadership in Intelligent Driving and AI-defined Mobility

Introduces XNGP ADAS rollout plan for the first batch of cities without HD map coverage Launches AI Valet Driver smart driving feature for urban commuting...

 Adtran launches Wi-Fi 6, 6E and 7 mesh routers for optimized in-home connectivity

 News summary: Operators need gateways that can deliver premium multigigabit services to households New SDG 8600 and 8700 Series with next-gen ARM processors offer up...

INSERTING and REPLACING Logitech Announces Second Quarter Fiscal Year 2024 Results

Company Raises FY 2024 Outlook LAUSANNE, Switzerland & SAN JOSE, Calif.–(BUSINESS WIRE)– Insert after last paragraph of release: GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS The...

Alipay+ partners LankaPay to enhance digital travel experience to and from Sri Lanka

More than 400,000 merchants in Sri Lanka will be able to accept cross-border digital payments from some of Asia’s most popular digital payment apps, with...

National Football League Teams Up with SES for Game Content Distribution

In a renewed partnership, SES’s hybrid distribution network to enable the NFL to reach over 35 partners in Europe, Asia and the Americas, deliver over...

ENHERTU® Approved in the EU as the First HER2 Directed Therapy for Patients with HER2 Mutant Advanced Non-Small Cell Lung Cancer

Approval based on DESTINY-Lung02 trial results where Daiichi Sankyo and AstraZeneca’s ENHERTU demonstrated a confirmed objective response rate of 49.0% and median duration of response...

Celltrion USA Announces U.S. FDA Approval of ZYMFENTRA® (infliximab-dyyb), the First and Only Subcutaneous infliximab, for the Treatment of People With Inflammatory Bowel Disease

ZYMFENTRA® is the first and only FDA-approved subcutaneous (SC) formulation of infliximab approved for the maintenance treatment of adult patients with moderately to severely active...

Philip Morris International Submits Applications to Commercialize IQOS ILUMA Tobacco Heating System to U.S. Food and Drug Administration

The applications mark the next step in the company’s mission to offer adults who smoke a portfolio of innovative, scientifically substantiated nicotine alternatives that can...

H.I.G. Realty Acquires a Portfolio of Three Buildings in a Prime Residential area of Madrid

LONDON–(BUSINESS WIRE)– H.I.G. Capital, LLC (“H.I.G.”), a leading global alternative investment firm with $59 billion of capital under management, is pleased to announce that one...

Deutsche Bahn brings 5G timing to German railways to meet new FRMCS standards with Adtran Oscilloquartz timing solution

News summary: National operator needed precise synchronization for its SDH network and the transition to a Future Railway Mobile Communication System Adtran’s Oscilloquartz timing technology...

Samsung Electronics Unveils Automotive Process Strategy at Samsung Foundry Forum 2023 EU

Samsung Foundry meets with customers and partners in the European market at annual event in Munich MUNICH–(BUSINESS WIRE)– Samsung Electronics Co., Ltd., a world leader...

4Moving Biotech Completes the Recruitment of Its Phase I Clinical Trial in Patients With Knee Osteoarthritis

LILLE, France–(BUSINESS WIRE)– 4Moving Biotech, a spin-off of 4P-Pharma dedicated to facing the global challenge of knee osteoarthritis, announces that it has reached a significant...

Alipay Enhances Accessible Payment Service in Support of Asian Para Games

HANGZHOU, China–(BUSINESS WIRE)– As part of Ant Group’s “Asian Para Games Support Initiative,” Alipay, the leading digital payment and lifestyle service platform, today announced it...

Protembis Announces FDA Approval of its Pivotal Investigational Device Exemption (IDE) Study

Novel Adaptive Superiority Trial Design of ProtEmbo® Cerebral Embolic Protection (CEP) System AACHEN, Germany–(BUSINESS WIRE)– Protembis GmbH (Protembis) a privately-held emerging cardiovascular medical device company,...